{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:07:42Z","timestamp":1788854862589,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004869","name":"Universit\u00e4t M\u00fcnster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The replicability of study results plays a central role, particularly in the context of real-world evidence (RWE). However, the evaluation of the agreement between two study results is not straightforward and different metrics are available. As an example for RWE, the surgical treatment of proximal humeral fractures in older patients using locked plate fixation (LPF) or reverse total shoulder arthroplasty (RTSA) was analyzed by two different studies based on the data of the largest German health insurance company, but the generalizability of the results should be further addressed. Independent data of a different German insurance company were used to emulate two existing studies evaluating different short- and long-term safety endpoints after surgical treatment of proximal humeral fracture in older patients using RTSA vs LPF. Study protocol was a priori registered. The sceptical p-value was used to judge the agreement between known original effect estimate (OES) and the observed emulated treatment effect estimate (EES) and compared to other existing binary agreement metrics. Overall, 7 (64%) of the 11 evaluated endpoints were successfully replicated. The Pearson correlation coefficient (\n                    <jats:inline-formula>\n                      <jats:tex-math>$$r_p$$<\/jats:tex-math>\n                    <\/jats:inline-formula>\n                    = 0.97) and the intra-class correlation coefficient (ICC3 = 0.94) indicated a good, positive correlation between original and emulation study. OES was successfully replicated for all short-term endpoints and surgical complications during follow-up (all\n                    <jats:inline-formula>\n                      <jats:tex-math>$$p_\\text {scep} &lt; 0.025$$<\/jats:tex-math>\n                    <\/jats:inline-formula>\n                    ). Furthermore, the treatment effect for surgical complications during follow-up was successfully replicated using an independent data base. The sceptical p-value was a useful and well-interpretable metric to evaluate the agreement between original and emulation study.\n                  <\/jats:p>\n                  <jats:p>Trial registration: A priori registered at ClinicalTrials.gov (Identifier: NCT06537024).<\/jats:p>","DOI":"10.1038\/s41598-026-70157-6","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:06:01Z","timestamp":1788851161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The replicability of real-world evidence for the surgical treatment of proximal humeral fractures in older patients evaluated using sceptical p-value"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3640-2995","authenticated-orcid":false,"given":"Jeanette","family":"Koeppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Fischhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Stolberg-Stolberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Raschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Faldum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Christoph","family":"Katthagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"10","key":"70157_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1097\/CORR.0000000000001776","volume":"479","author":"J K\u00f6ppe","year":"2021","unstructured":"K\u00f6ppe, J. et al. In-hospital complications are more likely to occur after reverse shoulder arthroplasty than after locked plating for proximal humeral fractures. Clin. Orthopaed. Relat. Res.479 (10), 2284\u20132292. https:\/\/doi.org\/10.1097\/CORR.0000000000001776 (2021).","journal-title":"Clinical Orthopaedics and Related Research"},{"issue":"48","key":"70157_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3238\/arztebl.m2021.0326","volume":"118","author":"J Stolberg-Stolberg","year":"2021","unstructured":"Stolberg-Stolberg, J. et al. The surgical treatment of proximal humeral fractures in elderly patients. Dtsch Arztebl Int.118 (48), 817\u2013823. https:\/\/doi.org\/10.3238\/arztebl.m2021.0326 (2021).","journal-title":"Dtsch Arztebl International"},{"issue":"7040","key":"70157_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/bmj.312.7040.1215","volume":"312","author":"N Black","year":"1996","unstructured":"Black, N. Why we need observational studies to evaluate the effectiveness of health care. BMJ312 (7040), 1215\u20131218. https:\/\/doi.org\/10.1136\/bmj.312.7040.1215 (1996).","journal-title":"BMJ"},{"issue":"7","key":"70157_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrd3501","volume":"10","author":"HG Eichler","year":"2011","unstructured":"Eichler, H. G. et al. Bridging the efficacy-effectiveness gap: a regulator\u2019s perspective on addressing variability of drug response. Nat. Rev. Drug Discov.10 (7), 495\u2013506. https:\/\/doi.org\/10.1038\/nrd3501 (2011).","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"70157_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jama.2018.10136","volume":"320","author":"J Corrigan-Curay","year":"2018","unstructured":"Corrigan-Curay, J., Sacks, L. & Woodcock, J. Real-world evidence and real-world data for evaluating drug safety and effectiveness. JAMA320 (9), 867\u2013868. https:\/\/doi.org\/10.1001\/jama.2018.10136 (2018).","journal-title":"JAMA"},{"issue":"5","key":"70157_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/cpt.1210","volume":"105","author":"SV Wang","year":"2019","unstructured":"Wang, S. V. et al. Using real-world data to extrapolate evidence from randomized controlled trials. Clin. Pharmacol. Ther.105(5), 1156\u20131163. https:\/\/doi.org\/10.1002\/cpt.1210 (2019).","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"9453","key":"70157_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","volume":"365","author":"PM Rothwell","year":"2005","unstructured":"Rothwell, P. M. External validity of randomised controlled trials: \u201cto whom do the results of this trial apply?\u2019\u2019. Lancet365 (9453), 82\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(04)17670-8 (2005).","journal-title":"The Lancet"},{"issue":"10","key":"70157_CR8","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1503\/cmaj.082007","volume":"180","author":"M Zwarenstein","year":"2009","unstructured":"Zwarenstein, M. & Treweek, S. What kind of randomized trials do we need?. CMAJ180 (10), 998\u20131000. https:\/\/doi.org\/10.1503\/cmaj.082007 (2009).","journal-title":"CMAJ"},{"key":"70157_CR9","doi-asserted-by":"publisher","unstructured":"Loudon, K., Treweek, S., Sullivan, F., Donnan, P., & Thorpe, K.E., Zwarenstein, M. The precis-2 tool: designing trials that are fit for purpose. BMJ350https:\/\/doi.org\/10.1136\/bmj.h2147 (2015).","DOI":"10.1136\/bmj.h2147"},{"issue":"5","key":"70157_CR10","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1510059","volume":"375","author":"I Ford","year":"2016","unstructured":"Ford, I. & Norrie, J. Pragmatic trials. New England J. Med.375 (5), 454\u2013463. https:\/\/doi.org\/10.1056\/NEJMra1510059 (2016).","journal-title":"New England Journal of Medicine"},{"key":"70157_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00402-003-0559-z","volume":"124","author":"M Bhandari","year":"2004","unstructured":"Bhandari, M. et al. Hierarchy of evidence: Differences in results between non-randomized studies and randomized trials in patients with femoral neck fractures. Arch. Orthop. Trauma Surg.124, 10\u20136. https:\/\/doi.org\/10.1007\/s00402-003-0559-z (2004).","journal-title":"Archives of orthopaedic and trauma surgery"},{"issue":"25","key":"70157_CR12","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","volume":"342","author":"J Concato","year":"2000","unstructured":"Concato, J., Shah, N. & Horwitz, R. I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England J. Med.342 (25), 1887\u20131892. https:\/\/doi.org\/10.1056\/NEJM200006223422507 (2000).","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"70157_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1001026","volume":"8","author":"S Golder","year":"2011","unstructured":"Golder, S., Loke, Y. K. & Bland, M. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: Methodological overview. PLoS Med.8(5), 1\u201313. https:\/\/doi.org\/10.1371\/journal.pmed.1001026 (2011).","journal-title":"PLOS Medicine"},{"issue":"10","key":"70157_CR14","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jclinepi.2011.01.005","volume":"64","author":"O Kuss","year":"2011","unstructured":"Kuss, O., Legler, T. & B\u00f6rgermann, J. Treatments effects from randomized trials and propensity score analyses were similar in similar populations in an example from cardiac surgery. J. Clin. Epidemiol.64 (10), 1076\u20131084. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.01.005 (2011).","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"70157_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/SLA.0000000000000256","volume":"259","author":"G Lonjon","year":"2014","unstructured":"Lonjon, G. et al. Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures. The Milbank Quarterly259 (1), 18\u201325. https:\/\/doi.org\/10.1097\/SLA.0000000000000256 (2014).","journal-title":"The Milbank Quarterly"},{"key":"70157_CR16","doi-asserted-by":"publisher","unstructured":"Anglemyer, A., Horvath, H.T., & Bero, L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database System. Rev.14 (4), https:\/\/doi.org\/10.1002\/14651858.MR000034.pub2 (2014).","DOI":"10.1002\/14651858.MR000034.pub2"},{"issue":"4","key":"70157_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","volume":"58","author":"S Schneeweiss","year":"2005","unstructured":"Schneeweiss, S. & Avorn, J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J. Clin. Epidemiol.58 (4), 323\u2013337. https:\/\/doi.org\/10.1016\/j.jclinepi.2004.10.012 (2005).","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"70157_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/cpt.1351","volume":"105","author":"JM Franklin","year":"2019","unstructured":"Franklin, J. M., Glynn, R. J., Martin, D. & Schneeweiss, S. Evaluating the use of nonrandomized real-world data analyses for regulatory decision making. Clin. Pharmacol. Therapet.105 (4), 867\u2013877. https:\/\/doi.org\/10.1002\/cpt.1351 (2019).","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"70157_CR19","unstructured":"US Food and Drug Administration, e.a.: Real-World Evidence. https:\/\/www.fda.gov\/science-research\/science-and-research-special-topics\/real-world-evidence"},{"issue":"9","key":"70157_CR20","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jval.2020.04.002","volume":"23","author":"LS Orsini","year":"2020","unstructured":"Orsini, L. S. et al. Improving transparency to build trust in real-world secondary data studies for hypothesis testing\u2013why, what, and how: Recommendations and a road map from the real-world evidence transparency initiative. Value Health23 (9), 1128\u20131136. https:\/\/doi.org\/10.1016\/j.jval.2020.04.002 (2020).","journal-title":"Value in Health"},{"issue":"1","key":"70157_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12874-022-01768-6","volume":"22","author":"F Liu","year":"2022","unstructured":"Liu, F. & Panagiotakos, D. Real-world data: a brief review of the methods, applications, challenges and opportunities. BMC Med. Res. Methodol.22 (1), 287. https:\/\/doi.org\/10.1186\/s12874-022-01768-6 (2022).","journal-title":"BMC Medical Research Methodology"},{"issue":"6","key":"70157_CR22","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/cpt.857","volume":"102","author":"JM Franklin","year":"2017","unstructured":"Franklin, J. M. & Schneeweiss, S. When and how can real world data analyses substitute for randomized controlled trials?. Clin. Pharmacol. Therapeut.102 (6), 924\u2013933. https:\/\/doi.org\/10.1002\/cpt.857 (2017).","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"70157_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41571-019-0167-7","volume":"16","author":"CM Booth","year":"2019","unstructured":"Booth, C. M., Karim, S. & Mackillop, W. J. Real-world data: towards achieving the achievable in cancer care. Nat. Rev. Clin. Oncol.16, 312\u2013325. https:\/\/doi.org\/10.1038\/s41571-019-0167-7 (2019).","journal-title":"Nat Rev Clin Oncol"},{"key":"70157_CR24","doi-asserted-by":"publisher","unstructured":"Koeppe, J., Katthagen, J.C., Rischen, R., Freistuehler, M., Faldum, A., Raschke, M.J., & Stolberg-Stolberg, J. Male sex is associated with higher mortality and increased risk for complications after surgical treatment of proximal humeral fractures. J. Clin. Med.10 (11), https:\/\/doi.org\/10.3390\/jcm10112500 (2021).","DOI":"10.3390\/jcm10112500"},{"issue":"8","key":"70157_CR25","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.jse.2022.12.020","volume":"32","author":"J Koeppe","year":"2023","unstructured":"Koeppe, J. et al. Increased complication rates of salvage reverse total shoulder arthroplasty (rtsa) after failed locked plate fixation compared with primary rtsa in the treatment of proximal humeral fractures in elderly patients. J. Shoulder Elbow Surg.32 (8), 1574\u20131583. https:\/\/doi.org\/10.1016\/j.jse.2022.12.020 (2023).","journal-title":"Journal of Shoulder and Elbow Surgery"},{"issue":"14","key":"70157_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3238\/arztebl.m2024.0059","volume":"121","author":"JC Katthagen","year":"2024","unstructured":"Katthagen, J. C. et al. Conservative versus operative treatment of proximal humerus fractures in older individuals. Dtsch Arztebl Int.121(14), 454\u2013460. https:\/\/doi.org\/10.3238\/arztebl.m2024.0059 (2024).","journal-title":"Dtsch Arztebl International"},{"key":"70157_CR27","doi-asserted-by":"publisher","unstructured":"Wu, A.-M. et al. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the global burden of disease study 2019. Lancet Healthy Longevity 2 (9), 580\u2013592 https:\/\/doi.org\/10.1016\/S2666-7568(21)00172-0 (2021).","DOI":"10.1016\/S2666-7568(21)00172-0"},{"key":"70157_CR28","doi-asserted-by":"publisher","unstructured":"Borgstr\u00f6m, F., Karlsson, L., Orts\u00e4ter, G., Norton, N., Halbout, P., Cooper, C., Lorentzon, M., McCloskey, E.V., Harvey, N.C., Javaid, M.K., & Kanis for the International Osteoporosis Foundation, J.A. Fragility fractures in Europe: burden, management and opportunities. Arch. Osteopor.15 (59), https:\/\/doi.org\/10.1007\/s11657-020-0706-y (2020).","DOI":"10.1007\/s11657-020-0706-y"},{"issue":"40","key":"70157_CR29","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3238\/arztebl.m2021.0238","volume":"118","author":"M Rupp","year":"2021","unstructured":"Rupp, M. et al. The incidence of fractures among the adult population of Germany. Dtsch Arztebl Int.118(40), 665\u2013669. https:\/\/doi.org\/10.3238\/arztebl.m2021.0238 (2021).","journal-title":"Dtsch Arztebl International"},{"issue":"33\u201334","key":"70157_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3238\/arztebl.m2023.0132","volume":"120","author":"J Koeppe","year":"2023","unstructured":"Koeppe, J. et al. The incidence of proximal humerus fracture. Dtsch Arztebl Int.120 (33\u201334), 555\u2013556. https:\/\/doi.org\/10.3238\/arztebl.m2023.0132 (2023).","journal-title":"Dtsch Arztebl International"},{"issue":"2","key":"70157_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2106\/JBJS.19.01071","volume":"102","author":"A Fraser","year":"2020","unstructured":"Fraser, A. et al. Reverse Shoulder Arthroplasty Is Superior to Plate Fixation at 2 Years for Displaced Proximal Humeral Fractures in the Elderly: A Multicenter Randomized Controlled Trial. J. Bone Joint Surg.102 (2), 477\u2013485. https:\/\/doi.org\/10.2106\/JBJS.19.01071 (2020).","journal-title":"The Journal of Bone and Joint Surgery"},{"key":"70157_CR32","doi-asserted-by":"publisher","unstructured":"Klug, A., Harth, J., Hoffmann, R. & Gramlich, Y. Surgical treatment of complex proximal humeral fractures in elderly patients: a matched-pair analysis of angular-stable plating vs. reverse shoulder arthroplasty. J. Shoulder Elbow Surg.29 (9), 1796\u20131803. https:\/\/doi.org\/10.1016\/j.jse.2020.01.073 (2020).","DOI":"10.1016\/j.jse.2020.01.073"},{"key":"70157_CR33","doi-asserted-by":"publisher","unstructured":"Giardella, A., Ascione, F., Mocchi, M., Berlusconi, M., Romano, A., Oliva, F., & Maradei, L. Reverse total shoulder versus angular stable plate treatment for proximal humeral fractures in over 65 years old patients. Muscles, Ligaments Tendons J.7 (2), 271\u2013278 https:\/\/doi.org\/10.11138\/mltj\/2017.7.2.271 (2017).","DOI":"10.11138\/mltj\/2017.7.2.271"},{"key":"70157_CR34","doi-asserted-by":"publisher","unstructured":"Porschke, F., Bockmeyer, J., Nolte, P.-C., Studier-Fischer, S., Guehring, T., & Schnetzke, M. More adverse events after osteosyntheses compared to arthroplasty in geriatric proximal humeral fractures involving anatomical neck. J. Clin. Med.10 (5) https:\/\/doi.org\/10.3390\/jcm10050979 (2021).","DOI":"10.3390\/jcm10050979"},{"key":"70157_CR35","doi-asserted-by":"publisher","unstructured":"Handoll, H., Brealey, S., Rangan, A., Keding, A., Corbacho, B., Jefferson, L., Chuang, L.-H., Goodchild, L., Hewitt, C., & Torgerson., D. The ProFHER (PROximal Fracture of the Humerus: Evaluation by Randomisation) trial \u2013 a pragmatic multicentre randomised controlled trial evaluating the clinical effectiveness and cost-effectiveness of surgical compared with non-surgical treatment for proximal fracture of the humerus in adults. Health Technol. Assess.19 (24), https:\/\/doi.org\/10.3310\/hta19240 (2019).","DOI":"10.3310\/hta19240"},{"issue":"3","key":"70157_CR36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/cpt.329","volume":"99","author":"SV Wang","year":"2016","unstructured":"Wang, S. V. et al. Transparency and reproducibility of observational cohort studies using large healthcare databases. Clin. Pharmacol. Therapeut.99 (3), 325\u2013332. https:\/\/doi.org\/10.1002\/cpt.329 (2016).","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"70157_CR37","doi-asserted-by":"publisher","unstructured":"Wang, S.V., Schneeweiss, S., Berger, M.L., Brown, J., Vries, F., Douglas, I., Gagne, J.J., Gini, R., Klungel, O., Mullins, C.D., Nguyen, M.D., Rassen, J.A., Smeeth, L., Sturkenboom, M., & Health Care Decision\u00a0Making. Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies v1.0. Pharmacoepidemiol. Drug Safety26 (9), 1018\u20131032 https:\/\/doi.org\/10.1002\/pds.4295 (2017).","DOI":"10.1002\/pds.4295"},{"issue":"1","key":"70157_CR38","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1038\/s41467-022-32310-3","volume":"13","author":"SV Wang","year":"2022","unstructured":"Wang, S. V., Sreedhara, S. K., Schneeweiss, S., Franklin, J. M. & Initiative, R. Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions. Nat. Communic.13(1), 5126. https:\/\/doi.org\/10.1038\/s41467-022-32310-3 (2022).","journal-title":"Nature Communications"},{"issue":"8","key":"70157_CR39","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n, M. A. & Robins, J. M. Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol.183 (8), 758\u2013764. https:\/\/doi.org\/10.1093\/aje\/kwv254 (2016).","journal-title":"American Journal of Epidemiology"},{"issue":"24","key":"70157_CR40","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hern\u00e1n","year":"2022","unstructured":"Hern\u00e1n, M. A., Wang, W. & Leaf, D. E. Target trial emulation: A framework for causal inference from observational data. JAMA328 (24), 2446\u20132447. https:\/\/doi.org\/10.1001\/jama.2022.21383 (2022).","journal-title":"JAMA"},{"issue":"10","key":"70157_CR41","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/CIRCULATIONAHA.120.051718","volume":"143","author":"JM Franklin","year":"2021","unstructured":"Franklin, J. M. et al. Emulating randomized clinical trials with nonrandomized real-world evidence studies. Circulation143 (10), 1002\u20131013. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051718 (2021).","journal-title":"Circulation"},{"issue":"16","key":"70157_CR42","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1001\/jama.2023.4221","volume":"329","author":"SV Wang","year":"2023","unstructured":"Wang, S. V., Schneeweiss, S. & Initiative, R.-D. Emulation of randomized clinical trials with nonrandomized database analyses: Results of 32 clinical trials. JAMA329 (16), 1376\u20131385. https:\/\/doi.org\/10.1001\/jama.2023.4221 (2023).","journal-title":"JAMA"},{"issue":"1","key":"70157_CR43","doi-asserted-by":"publisher","first-page":"000709","DOI":"10.1136\/bmjmed-2023-000709","volume":"3","author":"R Heyard","year":"2024","unstructured":"Heyard, R., Held, L., Schneeweiss, S. & Wang, S. V. Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of rct-duplicate data. BMJ Med.3 (1), 000709. https:\/\/doi.org\/10.1136\/bmjmed-2023-000709 (2024).","journal-title":"BMJ Medicine"},{"issue":"4","key":"70157_CR44","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/cpt.1633","volume":"107","author":"JM Franklin","year":"2020","unstructured":"Franklin, J. M. et al. Nonrandomized real-world evidence to support regulatory decision making: Process for a randomized trial replication project. Clin. Pharmacol. Therapeut.107 (4), 817\u2013826. https:\/\/doi.org\/10.1002\/cpt.1633 (2020).","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"70157_CR45","doi-asserted-by":"publisher","first-page":"71601","DOI":"10.7554\/eLife.71601","volume":"10","author":"TM Errington","year":"2021","unstructured":"Errington, T. M. et al. Investigating the replicability of preclinical cancer biology. eLife10, 71601. https:\/\/doi.org\/10.7554\/eLife.71601 (2021).","journal-title":"eLife"},{"issue":"2","key":"70157_CR46","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/rssa.12493","volume":"183","author":"L Held","year":"2020","unstructured":"Held, L. A new standard for the analysis and design of replication studies. J. R. Stat. Soc. Ser. A: Stat. Soc.183 (2), 431\u2013448. https:\/\/doi.org\/10.1111\/rssa.12493 (2020).","journal-title":"Journal of the Royal Statistical Society Series A: Statistics in Society"},{"issue":"2","key":"70157_CR47","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1214\/21-AOAS1502","volume":"16","author":"L Held","year":"2022","unstructured":"Held, L., Micheloud, C. & Pawel, S. The assessment of replication success based on relative effect size. Ann. Appl. Stat.16 (2), 706\u2013720. https:\/\/doi.org\/10.1214\/21-AOAS1502 (2022).","journal-title":"The Annals of Applied Statistics"},{"issue":"4","key":"70157_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/stan.12312","volume":"77","author":"C Micheloud","year":"2023","unstructured":"Micheloud, C., Balabdaoui, F. & Held, L. Assessing replicability with the sceptical p-value: Type-i error control and sample size planning. Stat. Neerlandica77 (4), 573\u2013591. https:\/\/doi.org\/10.1111\/stan.12312 (2023).","journal-title":"Statistica Neerlandica"},{"issue":"11","key":"70157_CR49","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jclinepi.2013.06.001","volume":"66","author":"O Kuss","year":"2013","unstructured":"Kuss, O. The z-difference can be used to measure covariate balance in matched propensity score analyses. J. Clin. Epidemiol.66 (11), 1302\u20131307. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.06.001 (2013).","journal-title":"Journal of Clinical Epidemiology"},{"issue":"35\u201336","key":"70157_CR50","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3238\/arztebl.2016.0597","volume":"113","author":"O Kuss","year":"2016","unstructured":"Kuss, O., Blettner, M. & B\u00f6rgermann, J. Propensity score: an alternative method of analyzing treatment effects. Dtsch Arztebl Int.113 (35\u201336), 597\u2013603. https:\/\/doi.org\/10.3238\/arztebl.2016.0597 (2016).","journal-title":"Dtsch Arztebl International"},{"issue":"26","key":"70157_CR51","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1002\/sim.10055","volume":"43","author":"L Held","year":"2024","unstructured":"Held, L. Beyond the two-trials rule. Stat. Med.43 (26), 5023\u20135042. https:\/\/doi.org\/10.1002\/sim.10055 (2024).","journal-title":"Statistics in Medicine"},{"key":"70157_CR52","unstructured":"US Food and Drug Administration, e.a.: Providing clinical evidence of effectiveness for human drug and biological products. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/providing-clinical-evidence-effectiveness-human-drug-and-biological-products"},{"issue":"3","key":"70157_CR53","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/jrsm.1538","volume":"13","author":"L Held","year":"2022","unstructured":"Held, L., Matthews, R., Ott, M. & Pawel, S. Reverse-bayes methods for evidence assessment and research synthesis. Res. Synth Methods13 (3), 295\u2013314. https:\/\/doi.org\/10.1002\/jrsm.1538 (2022).","journal-title":"RESEARCH SYNTHESIS METHODS"},{"issue":"8","key":"70157_CR54","doi-asserted-by":"publisher","first-page":"202300232","DOI":"10.1002\/bimj.202300232","volume":"66","author":"C Micheloud","year":"2024","unstructured":"Micheloud, C. & Held, L. The replication of equivalence studies. Biometr. J.66 (8), 202300232. https:\/\/doi.org\/10.1002\/bimj.202300232 (2024).","journal-title":"Biometrical Journal"},{"key":"70157_CR55","doi-asserted-by":"publisher","unstructured":"Altman, D. G. & Bland, J. M. Statistics notes: Absence of evidence is not evidence of absence. BMJ311 (7003), 485. https:\/\/doi.org\/10.1136\/bmj.311.7003.485 (1995).","DOI":"10.1136\/bmj.311.7003.485"},{"issue":"11","key":"70157_CR56","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.joca.2022.06.005","volume":"30","author":"X Jin","year":"2022","unstructured":"Jin, X., Ding, C., Hunter, D. J. & Gallego, B. Effectiveness of vitamin d supplementation on knee osteoarthritis - a target trial emulation study using data from the osteoarthritis initiative cohort. Osteoarthr. Cartil.30 (11), 1495\u20131505. https:\/\/doi.org\/10.1016\/j.joca.2022.06.005 (2022).","journal-title":"Osteoarthritis and Cartilage"},{"key":"70157_CR57","doi-asserted-by":"publisher","unstructured":"Jang, H. Y., Kim, I..-W. & Oh, J. M. Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data. Front. Pharmacol. 13, https:\/\/doi.org\/10.3389\/fphar.2022.928121 (2022).","DOI":"10.3389\/fphar.2022.928121"},{"issue":"6","key":"70157_CR58","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/cpt.2800","volume":"113","author":"D Merola","year":"2023","unstructured":"Merola, D. et al. The aetion coalition to advance real-world evidence through randomized controlled trial emulation initiative: Oncology. Clin. Pharmacol. Therapeut.113 (6), 1217\u20131222. https:\/\/doi.org\/10.1002\/cpt.2800 (2023).","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"70157_CR59","doi-asserted-by":"publisher","unstructured":"Antoine, A., P\u00e9rol, D., Robain, M., Bachelot, T., Choquet, R., Jacot, W., Ben Hadj Yahia, B., Grinda, T., Delaloge, S., Lasset, C., Drouet, Y.: Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulation. Eur. J. Cancer213, 115072 https:\/\/doi.org\/10.1016\/j.ejca.2024.115072 (2024).","DOI":"10.1016\/j.ejca.2024.115072"},{"issue":"7","key":"70157_CR60","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/jnnp-2023-332603","volume":"95","author":"A Signori","year":"2024","unstructured":"Signori, A. et al. Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the msbase registry. J. Neurol. Neurosurg. Psychiatr.95 (7), 620\u2013625. https:\/\/doi.org\/10.1136\/jnnp-2023-332603 (2024).","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"1","key":"70157_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/art.42968","volume":"77","author":"E D\u2019Andrea","year":"2024","unstructured":"D\u2019Andrea, E. et al. Efficacy versus effectiveness: The horizon-pivotal fracture trial and its emulation in claims data. Arthr. Rheumatol.77 (1), 12\u201321. https:\/\/doi.org\/10.1002\/art.42968 (2024).","journal-title":"Arthritis & Rheumatology"},{"key":"70157_CR62","doi-asserted-by":"publisher","unstructured":"Koeppe, J., Micheloud, C., Erdmann, S., Heyard, R., & Held, L. Assessing the replicability of rcts in rwe emulations. BMC Med. Res. Methodol.25 (141) https:\/\/doi.org\/10.1186\/s12874-025-02589-z (2025).","DOI":"10.1186\/s12874-025-02589-z"},{"issue":"10","key":"70157_CR63","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00104-021-01491-w","volume":"92","author":"J Stolberg-Stolberg","year":"2021","unstructured":"Stolberg-Stolberg, J. et al. Influence of complications and comorbidities on length of hospital stay and costs for surgical treatment of proximal humeral fractures. Chirurg92 (10), 907\u2013915. https:\/\/doi.org\/10.1007\/s00104-021-01491-w (2021).","journal-title":"Chirurg"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-70157-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-70157-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-70157-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:26:04Z","timestamp":1788852364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-70157-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70157"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-70157-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JK, JSS and JCK report research funding from the German Society for Trauma Surgery sponsored by Stryker, out-side the submitted work. All the remaining authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by Ethics Committee Westfalen-Lippe (no. 2022-300-f-S). Due to the retrospective nature of the study, the need to obtain the informed consent was waived by the Ethics Committee Westfalen-Lippe.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As for anonymity of insurance data, no prior written informed consent for publication of the data had to be obtained.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28068"}}